PureTech Announces Issuance of U.S. Patent Covering Compositions of Matter for Immuno-Oncology Program Targeting Galectin-9 – Business Wire

PureTech Announces Issuance of U.S. Patent Covering Compositions of Matter for Immuno-Oncology Program Targeting Galectin-9  Business Wire

BOSTON–(BUSINESS WIRE)–PureTech Health plc (LSE: PRTC) (“PureTech”), an advanced biopharmaceutical company developing novel medicines for …